If You’d Invested $10,000 in Canopy Growth (TSX:WEED) at Legalization, This Is How Much You’d Have Today

Will 2020 be a better year for Canopy Growth Corp (TSX:WEED)(NYSE:CGC)?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Canopy Growth (TSX:WEED)(NYSE:CGC) has seen much better days. The stock, along with many of its peers, has seen some epic declines this year. Since the beginning of 2019, Canopy Growth’s shares have fallen by 36% as of the end of last week. However, that doesn’t tell the whole story, as the whole cannabis sector has been struggling since recreational marijuana was legalized in Canada on October 17, 2018. Back then, shares of Canopy Growth were trading at around $66. A $10,000 investment would have been enough to buy you approximately 152 shares of the popular pot stock. Today, however, those shares would be worth about $3,800.

WEED Chart

WEED data by YCharts.

Why has Canopy Growth fallen 62% since legalization?

There have been plenty of reasons that investors can point to as to why Canopy Growth and other cannabis stocks have struggled so mightily since October 2018. The most obvious reason is that Canopy Growth wasn’t worth its ridiculous valuation in the first place. Even in January, the stock was back up to around a $20 billion valuation, putting alongside top blue-chip stocks on the TSX that were not only more established but turning profits as well. A lack of profitability remains a problem today, and although Canopy Growth is at a more modest market cap of around $9 billion, the case could be made that it’s still too expensive.

Trading at 25 times its sales, investors continue to pay high premiums to own a piece of the company. By comparison, top growth stock Facebook only trades at nine times its sales, and it’s also profitable. Cannabis investors have long been romanced by the industry’s promises of high growth that they’ve allowed themselves to pay obscene amounts of money for companies like Canopy Growth that still have a lot to prove.

The challenges that Canopy Growth faced ultimately led to the departure of its longtime leader, Bruce Linton, which was another reason that investors sold their shares in the company. Long seen as the company’s visionary, Linton was also able to generate a lot of excitement in the company and helped build it up to the industry giant that it is today.

Another reason the industry has struggled is a result of the CannTrust scandal, which led to concerns among many investors in the industry, prompting them to sell their shares in cannabis stocks as quickly as possible.

Can Canopy Growth bounce back?

Canopy Growth has a long way to go in winning back investors that it has lost along the way. And while there’s certainly the potential for the stock to recover from this significant sell-off, I wouldn’t expect the stock to get back to the egregious valuation that it was at before.

Cannabis investors have been more cognizant of valuations in the industry, especially with the recreational marijuana market not performing as well as many had hoped in year one. It’s been a sobering reality for the industry, and although 2020 could be a stronger year for marijuana, that may not be enough for Canopy Growth to get back to where it was in its heyday. I wouldn’t be surprised if the stock were to get back to $40 this coming year, but anything beyond that looks like a long shot.

Should you invest $1,000 in Canopy Growth right now?

Before you buy stock in Canopy Growth, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Canopy Growth wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to its CEO, Mark Zuckerberg, is a member of The Motley Fool's board of directors. David Gardner owns shares of Facebook. Tom Gardner owns shares of Facebook. The Motley Fool owns shares of and recommends Facebook.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »